Doubling Stocks

These 2 Biotech Stocks Could Double – Or More – This Year

by RobH
February 3, 2021April 17, 2021

Today’s article highlights two clinical-stage biotech stocks that analysts believe are not only likely to be winners this year, but that have the potential to… Read More »These 2 Biotech Stocks Could Double – Or More – This Year

These Low-Priced Stocks Offer The Potential For Large Returns – With Managed Risk

by Bob Mitchell
October 11, 2017April 17, 2021

With low-priced stocks comes the potential for large returns. In fact, today’s article notes that stocks priced under $5 have the highest average return. Of… Read More »These Low-Priced Stocks Offer The Potential For Large Returns – With Managed Risk